Duna Massillon

Duna Massillon is an experienced scientist and lab manager specializing in cell therapy development, currently serving at Athenex since June 2021. Prior to this role, Duna worked at Roswell Park Comprehensive Cancer Center in the cGMP CAR T cell manufacturing from June 2019 to June 2021. Duna's career includes notable positions such as Director of Preclinical Studies at Buffalo Biolabs, where responsibilities encompassed consulting on protocol development and leading efficacy and toxicity studies, and Senior Scientist at Cleveland Biolabs, focusing on drug-induced liver toxicity. Additional experience includes roles in oncology research at Roswell Park Cancer Institute, writing SOPs as a Research Scientist at Cleveland Biolabs, and serving as an Assistant Professor at Case Western Reserve University, where Duna supervised and trained research staff and implemented independent research programs.